Jason Hannon - 21 Jun 2021 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)

Role
Director
Signature
/s/ Kimberley A. Elting, Chief Legal and Development Officer, by power of attorney
Issuer symbol
OFIX
Transactions as of
21 Jun 2021
Net transactions value
$0
Form type
4
Filing time
23 Jun 2021, 16:21:55 UTC
Next filing
08 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OFIX Common Stok Award $0 +4,313 +84% $0.000000 9,431 21 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The award vests in full on the first anniversary of the grant date, June 21, 2021.